Chinese Journal of Tissue Engineering Research ›› 2013, Vol. 17 ›› Issue (8): 1497-1504.doi: 10.3969/j.issn.2095-4344.2013.08.027

Previous Articles     Next Articles

Targeting effect and application of liver cancer targeting vector drugs

He Er-xia1, Nie Zhong-shi2, Zhang Ying-hui1, Lin Hai-feng1   

  1. 1 Department of Medical Oncology, Hainan Provincial Nong Ken Hospital, Haikou 570311, Hainan Province, China
    2 Department of Radiology, Hainan Provincial Nong Ken Hospital, Haikou 570311, Hainan Province, China
  • Received:2012-09-18 Revised:2012-11-27 Online:2013-02-19 Published:2013-02-19
  • Contact: Lin Hai-feng, Chief physician, Department of Medical Oncology, Hainan Provincial Nong Ken Hospital, Haikou 570311, Hainan Province, China niezhongshi@163.com
  • About author:He Er-xia★, Master, Associate chief physician, Department of Medical Oncology, Hainan Provincial Nong Ken Hospital, Haikou 570311, Hainan Province, China heerxia@163.com

Abstract:

BACKGROUND: Liver cancer is one of the common malignant tumor, and choosing the effective therapy and treatment method has great significance for the treatment of liver cancer.
OBJECTIVE: To evaluate the targeting therapy effect of the carrier sustained-release chemotherapy drugs for the treatment of liver cancer.
METHODS: The clinical commonly used liver cancer chemotherapy drugs included the 5-fluorouracil, mitomycin and epirubicin vector sustained-release system, and the tumor targeting characteristics and suppression and killing effect of these cancer chemotherapy drugs on the tumor were analyzed. A total of 163 patients with advanced liver cancer were selected from Department of Medical Oncology, Hainan Provincial Nong Ken Hospital. The patients were treated with 5-fluorouracil, mitomycin and epirubicin combined with the adjuvant treatment of transcatheter arterial chemoembolization, and then the clinical effect was observed.
RESULTS AND CONCLUSION: 5-fluorouracil, mitomycin and epirubicin vector sustained release system show the targeting characteristics to liver tumor through different mechanisms, and have strong inhibiting and killing effect on liver tumors. And the cancer chemotherapy drugs can reduce the drug consumption, decrease the toxicity side effect and thus improve the therapeutic effect. In addition, the combination of transcatheter arterial chemoembolization can prolong the survival of the patients and improve the therapeutic effect of liver cancer.

Key words: biomaterials, academic discussion of biomaterials, liver cancer, target, 5-fluorouracil, mitomycin, epirubicin, transcatheter arterial chemoembolization, hepatic artery, portal vein, cells, computed tomography, angiography, provincial grants-supported paper

CLC Number: